Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.9287
+0.0756 (8.86%)
At close: Oct 8, 2025, 4:00 PM EDT
0.9300
+0.0013 (0.14%)
After-hours: Oct 8, 2025, 7:19 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $77.32 million as of October 8, 2025. Its market cap has decreased by -34.38% in one year.
Market Cap
77.32M
Enterprise Value
-32.29M
1-Year Change
-34.38%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $77.32M, a decrease of -74.37%. That is a compound annual growth rate of -23.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 77.32M | -2.46% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |